Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 2151 - 2175 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AA08
  • Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • nLc4Cer(d18:1/26:1(17Z))
70699272 1364.890793 C70H128N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AP08
  • Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261939 1364.890793 C70H128N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR08
  • Cytolipin R(d18:1/26:1(17Z))
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261579 1364.890793 C70H128N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT08
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261595 1364.890793 C70H128N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF08
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261675 1364.890793 C70H128N2O23
Diacylglycerophosphoinositolglycans LMGP15010200
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(17:0/14:0)
126457568 1606.774308 C70H127O38P
Diacylglycerophosphoinositolglycans LMGP15010181
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:0/18:1(9Z))
126457549 1526.799733 C70H127O33P
Diacylglycerophosphoinositolglycans LMGP15010186
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:1(9Z)/18:0)
126457554 1526.799733 C70H127O33P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN01
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260268 1509.829044 C70H127NO33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC02
  • Forssman antigen(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260181 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD02
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Para-Forssman x3b(d18:1/18:0)
44260189 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC02
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260389 1457.860617 C70H127N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD02
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260397 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AC02
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260501 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AE02
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260517 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AO02
  • GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260597 1457.860617 C70H127N3O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AJ02
  • GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260685 1457.860617 C70H127N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK02
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • nLc5Cer(d18:1/18:0)
44261053 1457.860617 C70H127N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN02
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • P antigen(d18:1/18:0)
44261285 1457.860617 C70H127N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE02
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261421 1457.860617 C70H127N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD02
  • Forssman-like iGb4(d18:1/18:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261861 1457.860617 C70H127N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO02
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261925 1457.860617 C70H127N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG02
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261677 1457.860617 C70H127N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AN07
  • GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260594 1377.886042 C70H127N3O23
Diacylglycerophosphoinositolglycans LMGP15010187
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(19:1(9Z)/18:1(9Z))
126457555 1524.784083 C70H125O33P

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024